Boston Scientific Corp (NYSE:BSX)

30.31
Delayed Data
As of May 25
 -0.09 / -0.30%
Today’s Change
24.54
Today|||52-Week Range
30.84
+22.27%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$41.2B

Company Description

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions. The Rhythm Management segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal, and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Contact Information

Boston Scientific Corp.
300 Boston Scientific Way
Marlborough Massachusetts 01752-1234
P:(508) 683-4000
Investor Relations:
(508) 683-5565

Employees

Shareholders

Mutual fund holders58.00%
Other institutional34.14%
Individual stakeholders1.48%

Top Executives

Michael F. MahoneyChairman, President & Chief Executive Officer
Edward MackeyExecutive Vice President-Operations
John Bradley SorensonSenior Vice President-Manufacturing & Supply Chain
Daniel J. BrennanChief Financial Officer & Executive Vice President
Ian T. MeredithGlobal Chief Medical Officer & Executive VP